A Dark Vector Cognition product

Item 6. EXHIBITS ( documents filed or furnished with this report; # compensatory plans or arrangements)

4K characters. Original on sec.gov ·

Item 6. EXHIBITS ( documents filed or furnished with this report; # compensatory plans or arrangements)

The 2 tables in Item 6. EXHIBITS ( documents filed or furnished with this report; # compensatory plans or arrangements) as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

10.1Offer Letter dated October 1, 2026 between Joseph M. Fitzgerald and Boston Scientific Corporation (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on October 7, 2026, File No. 1-11083). #
22Subsidiary Issuer of Guaranteed Securities (incorporated herein by reference to Exhibit 22 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, filed on August 1, 2025, File No. 1-11083).
31.1*Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.SCH*Inline XBRL Taxonomy Extension Schema Document.
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on November 2, 2026.

BOSTON SCIENTIFIC CORPORATION
By:/s/ Jonathan Monson
Name:Jonathan Monson
Title:Executive Vice President and Chief Financial Officer

Previous: Item 5. OTHER INFORMATION